Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, China.
J Control Release. 2023 Jun;358:78-97. doi: 10.1016/j.jconrel.2023.04.020. Epub 2023 Apr 29.
The establishment of in vitro models of the BBB is significant for the evaluation of the mechanism and permeability of drugs and their sustained-release formulations across the BBB. Among the different models, the immortalized human cell line hCMEC/D3 has the potential to be used for a standardized in vitro BBB model due to its high throughput, reproducibility, homology and low cost. The high permeability of the paracellular pathway and the low expression of both certain transporters and metabolic enzymes in this model lead to low physiological levels of physical, transport and metabolic barriers, thus limiting the application of these cells. The barrier properties of this model have been improved in different studies by various means. However, no systematic review has been conducted on the optimization of model-building conditions or on the regulation and expression of transporters in the models. Some existing reviews focus on the overall description of the entire field of blood-brain barrier in vitro models, lacking in-depth and systematic reviews on the experimental details and model evaluation methods based on hCMEC/D3.This paper deals with a detailed review on the optimization of multiple aspects and modalities of the hCMEC/D3 cell culture process, including initial medium, optimal serum levels, Transwell membrane materials, supra-membrane supports, inoculum density, endogenous growth factor, exogenous drug levels, co-culture and transfection methods, to provide references for the establishment and evaluation of hCMEC/D3 cell models.
体外 BBB 模型的建立对于评估药物及其跨 BBB 缓释制剂的作用机制和通透性具有重要意义。在不同的模型中,永生化人细胞系 hCMEC/D3 具有成为标准化体外 BBB 模型的潜力,因为它具有高通量、可重复性、同源性和低成本的特点。该模型的细胞旁途径通透性高,某些转运体和代谢酶的表达水平低,导致物理、转运和代谢屏障的生理水平低,从而限制了这些细胞的应用。在不同的研究中,通过各种手段改善了该模型的屏障特性。然而,目前还没有关于模型构建条件的优化或模型中转运体的调控和表达的系统评价。一些现有的综述文章主要集中在体外血脑屏障模型的整体描述上,缺乏基于 hCMEC/D3 的实验细节和模型评估方法的深入和系统的综述。本文详细综述了 hCMEC/D3 细胞培养过程中多个方面和模式的优化,包括初始培养基、最佳血清水平、Transwell 膜材料、跨膜支架、接种密度、内源性生长因子、外源性药物水平、共培养和转染方法,为 hCMEC/D3 细胞模型的建立和评价提供参考。